Sean McCutcheon
Stock Analyst at Raymond James
(2.39)
# 2,540
Out of 5,172 analysts
12
Total ratings
33.33%
Success rate
7.7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sean McCutcheon
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BBOT BridgeBio Oncology Therapeutics | Initiates: Outperform | $24 | $8.68 | +176.50% | 1 | Jan 9, 2026 | |
| RVMD Revolution Medicines | Maintains: Strong Buy | $72 → $76 | $95.78 | -20.65% | 2 | Oct 17, 2025 | |
| VIR Vir Biotechnology | Initiates: Outperform | $12 | $9.10 | +31.87% | 1 | Jul 11, 2025 | |
| JANX Janux Therapeutics | Initiates: Outperform | $65 | $14.06 | +362.30% | 1 | Jul 11, 2025 | |
| CMPX Compass Therapeutics | Reinstates: Outperform | $9 | $5.15 | +74.76% | 1 | Jul 1, 2025 | |
| BDTX Black Diamond Therapeutics | Reinstates: Outperform | $11 | $2.11 | +421.33% | 1 | Jul 1, 2025 | |
| ENGN enGene Holdings | Initiates: Outperform | $23 | $7.21 | +219.00% | 1 | Nov 27, 2024 | |
| XNCR Xencor | Maintains: Strong Buy | $58 → $40 | $12.13 | +229.76% | 1 | Jun 14, 2024 | |
| CYTK Cytokinetics | Maintains: Outperform | $92 → $70 | $61.70 | +13.45% | 2 | May 23, 2024 | |
| LEGN Legend Biotech | Initiates: Outperform | $86 | $17.41 | +393.97% | 1 | Mar 13, 2024 |
BridgeBio Oncology Therapeutics
Jan 9, 2026
Initiates: Outperform
Price Target: $24
Current: $8.68
Upside: +176.50%
Revolution Medicines
Oct 17, 2025
Maintains: Strong Buy
Price Target: $72 → $76
Current: $95.78
Upside: -20.65%
Vir Biotechnology
Jul 11, 2025
Initiates: Outperform
Price Target: $12
Current: $9.10
Upside: +31.87%
Janux Therapeutics
Jul 11, 2025
Initiates: Outperform
Price Target: $65
Current: $14.06
Upside: +362.30%
Compass Therapeutics
Jul 1, 2025
Reinstates: Outperform
Price Target: $9
Current: $5.15
Upside: +74.76%
Black Diamond Therapeutics
Jul 1, 2025
Reinstates: Outperform
Price Target: $11
Current: $2.11
Upside: +421.33%
enGene Holdings
Nov 27, 2024
Initiates: Outperform
Price Target: $23
Current: $7.21
Upside: +219.00%
Xencor
Jun 14, 2024
Maintains: Strong Buy
Price Target: $58 → $40
Current: $12.13
Upside: +229.76%
Cytokinetics
May 23, 2024
Maintains: Outperform
Price Target: $92 → $70
Current: $61.70
Upside: +13.45%
Legend Biotech
Mar 13, 2024
Initiates: Outperform
Price Target: $86
Current: $17.41
Upside: +393.97%